Creo Medical Limited (CREO.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 40.83M |
| Enterprise Value | 32.53M |
| P/E Ratio | -2.48 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 7.22 |
| Price/Book Ratio | 0.98 |
| Enterprise/Revenue | 6.72 |
| Enterprise/EBITDA | -2.64 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -2.69 |
| Operating Margin | -2.67 |
AD
Management Effectiveness
| Return On Assets | -0.33 |
| Return On Equity | -0.38 |
Income Statement
| Revenue | 6M |
| Revenue/Share | 0.02 |
| Gross Profit | 1.4M |
| EBITDA | -19.7M |
| Net Income | 5.3M |
| Diluted EPS | 0.01 |
Balance Sheet
| Total Cash | 7.4M |
| Total Cash/Share | 0.02 |
| Total Debt | 3.9M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 2.79 |
| Book Value Per Share | 0.12 |
Price History
| 52-Week Change | 2.27 |
| 52-Week High | 18.5 |
| 52-Week Low | 9.5 |
| Moving Average 50 Days | 11.88 |
| Moving Average 200 Days | 13.08 |
Statistics
| Average Volume | 699,524 |
| Shares Outstanding | 449.14M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 259:250 |
| Last Split Date | February 16, 2023 |
AD
